- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
Results
1000
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
1,000 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
STC | US$73.25 | 4.6% | 56.1% | US$2.0b | US$76.00 | PE46.7x | E48.6% | 2.6% | Insurance | ||
2083 | ر.س62.40 | -1.0% | -21.0% | ر.س15.6b | ر.س80.75 | PE33.8x | E28.4% | 3.5% | Utilities | ||
CLX | UK£0.49 | 2.1% | -58.1% | UK£42.9m | UK£1.09 | PE1072.6x | E72.4% | 1.9% | Tech | ||
3436 | JP¥2,341.00 | -9.7% | 13.3% | JP¥818.6b | JP¥2,750.88 | PE26.2x | E24.3% | 2.3% | Semiconductors | ||
3738 | HK$1.15 | -7.3% | -58.3% | HK$2.6b | HK$6.49 | PS1.3x | E66.6% | n/a | Software | ||
ELM | UK£1.53 | 4.4% | 39.8% | UK£902.5m | UK£1.61 | PE41.2x | E29.7% | 1.1% | Materials | ||
UCB | €152.05 | 8.5% | 90.7% | €28.8b | €146.07 | PE120.2x | E33.4% | 0.9% | Pharmaceuticals & Biotech | ||
SBS | €41.30 | -1.4% | -18.2% | €502.0m | €42.33 | PE41.3x | E21.9% | 1.3% | Healthcare | ||
SINCH | SEK 28.54 | 8.2% | 3.0% | SEK 24.1b | SEK 37.39 | PE122.9x | E50.2% | n/a | Software | ||
8936 | NT$81.10 | -3.6% | 121.3% | NT$20.1b | NT$102.00 | PE28.1x | E33.3% | 1.8% | Capital Goods | ||
300143 | CN¥7.37 | -1.3% | -32.3% | CN¥4.7b | CN¥10.12 | PE53.7x | E28.5% | 0% | Healthcare | ||
1860 | HK$1.85 | -8.0% | -51.7% | HK$2.8b | HK$5.50 | PE13.8x | E20.3% | n/a | Media | ||
RED | AU$0.38 | -7.4% | 102.7% | AU$2.6b | n/a | PE52.3x | E47.5% | n/a | Materials | ||
VAC | US$85.46 | -3.3% | -33.2% | US$3.0b | US$114.33 | PE14x | E22.9% | 3.6% | Consumer Services | ||
1211 | HK$235.80 | -3.0% | -13.1% | HK$754.8b | HK$295.74 | PE20.9x | E15.3% | 1.4% | Automobiles | ||
SMAR | US$48.40 | 0.2% | 12.1% | US$6.7b | US$53.39 | PS6.7x | E54.6% | n/a | Software | ||
2755 | CN¥9.53 | -6.5% | 13.7% | CN¥8.8b | CN¥13.00 | PS5.7x | E90.7% | 0% | Pharmaceuticals & Biotech | ||
RAY B | SEK 140.60 | 0.6% | 98.0% | SEK 4.8b | SEK 195.00 | PE47.9x | E33.6% | 0.5% | Healthcare | ||
VTSC | €56.45 | -4.8% | -26.2% | €2.3b | €74.72 | PB0.8x | E62.7% | 0.4% | Automobiles | ||
BEG | UK£1.00 | -4.2% | -24.5% | UK£156.2m | UK£1.71 | PE107.6x | E53.7% | 4.0% | Commercial Services | ||
MXI | AU$2.00 | -3.8% | -27.0% | AU$110.3m | AU$2.74 | PE17.2x | E28.9% | 2.9% | Capital Goods | ||
AZT | NOK 24.70 | 2.1% | -35.4% | NOK 1.3b | NOK 27.50 | PE71.9x | E48.1% | n/a | Pharmaceuticals & Biotech | ||
4194 | JP¥7,650.00 | -1.9% | 0.1% | JP¥303.2b | JP¥9,266.67 | PE21.7x | E11.2% | n/a | Commercial Services | ||
SACH | US$2.73 | 4.6% | -28.3% | US$129.5m | US$4.25 | PE11.2x | E16.7% | 16.1% | Diversified Financials |